📣 PETAL Consortium is in the news! Nathan Roberts, MD, PETAL’s principal investigator at UVA Health, was interviewed about PETAL Consortium’s international research efforts focused on rare blood cancers. PETAL was featured on 29 News, Haystack News, WBTV, WTOC, WBRC, KWCH, Arizona’s Family, KKTV, WKYT, and KNOP News 2. 🌸 Read more: https://lnkd.in/e4FxzSr6 Special thank you to our sponsors/partners: Acrotech Biopharma Inc, Kyowa Kirin, Inc.- U.S., Pfizer, Secura Bio, Inc., Daiichi Sankyo US, Regeneron, Corvus Pharmaceuticals, Broad Institute of MIT and Harvard, Massachusetts Institute of Technology, and EpiCypher, Inc. PETAL sites: Massachusetts General Hospital , Dana-Farber Cancer Institute, University of Pennsylvania, University of Cape Town, Hackensack Meridian Health, UVA Health, Royal Adelaide Hospital, University of Colorado, Mayo Clinic, Cleveland Clinic, Moffitt Cancer Center, The Ohio State University, City of Hope, UCSF Health, Boston Medical Center (BMC), Emory University, OhioHealth, Kyoto University, Peter MacCallum Cancer Centre, University of Utah Health University of Chicago, and Vanderbilt University.
